All Stories

  1. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) in Brazilian healthcare professionals: The PROFISCOV trial
  2. Surveillance of SARS-CoV-2 in Healthcare Workers Before and After COVID-19 Vaccination: A Cohort Study in a Primary Care Unit of Brazil
  3. Surveillance of SARS-CoV-2 in Healthcare Workers before and after COVID-19 Vaccination: A Cohort Study in a Primary Care Unit of Brazil
  4. Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac) in Brazilian Healthcare Professionals: The PROFISCOV Trial
  5. Increasing HIV screening in a secondary hospital emergency department in Brazil: searching for opportunities
  6. Missed opportunities for HIV diagnosis among incarcerated people in the Federal District, Brasilia, Brazil
  7. Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
  8. Seroprevalence of SARS-CoV-2 and Vaccination Coverage among Residents of a Lower-Middle-Class Population in the Federal District, Brazil
  9. Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge
  10. Accuracy of point-of-care Panbio™ SARS-CoV-2 antigen-detection test in a socioeconomically vulnerable population in Brazil
  11. Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study
  12. The role of pets in SARS-CoV-2 transmission: an exploratory analysis
  13. SARS CoV-2 seroprevalence and diagnostic accuracy during a COVID-19 outbreak in a major penitentiary complex in Brazil, June to July 2020
  14. Consentimento informado para a testagem do HIV em unidades de pronto-socorro e direitos humanos dos pacientes: à procura de equilíbrio
  15. Frequency of exposure to arboviruses and characterization of Guillain Barré syndrome in a clinical cohort of patients treated at a tertiary referral center in Brasília, Federal District
  16. Informed consent for HIV screening in the emergency departments and human rights in patient care: seeking the right balance
  17. Neonatal healthcare-associated infections in Brazil: systematic review and meta-analysis
  18. Reply to Nguyen and Frost
  19. Interventions for American cutaneous and mucocutaneous leishmaniasis
  20. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial
  21. Accuracy of diagnostic tests for American tegumentary leishmaniasis: a systematic literature review with meta‐analyses
  22. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
  23. Visceral leishmaniasis lethality in Brazil: an exploratory analysis of associated demographic and socioeconomic factors
  24. HIV prevalence in recently incarcerated adult males in the Federal District, Brasilia, Brazil
  25. A cross-sectional approach including dog owner characteristics as predictors of visceral leishmaniasis infection in dogs
  26. Treatment for human visceral leishmaniasis: a cost‐effectiveness analysis for Brazil
  27. Guillain–Barré syndrome associated with Zika virus infection in Brazil: a cost-of-illness study
  28. Improving the reference standard for the diagnosis of canine visceral leishmaniasis: a challenge for current and future tests
  29. Late-onset sepsis and mortality among neonates in a Brazilian Intensive Care Unit: a cohort study and survival analysis
  30. Validation and reliability of the rapid diagnostic test ‘SD Bioeasy Dengue Duo’ for dengue diagnosis in Brazil: a phase III study
  31. Effectiveness of dog collars impregnated with 4% deltamethrin in controlling visceral leishmaniasis in Lutzomyia longipalpis (Diptera: Psychodidade: Phlebotominae) populations
  32. Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial
  33. Mucosal leishmaniasis: urgent need for more research
  34. Cost of visceral leishmaniasis care in Brazil
  35. Deficiência de glicose-6-fosfato desidrogenase e uso de primaquina: estimativa de custos de profissionais por macrocusteio e microcusteio
  36. Visceral leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?
  37. Poor efficacy of preemptive amoxicillin clavulanate for preventing secondary infection from Bothrops snakebites in the Brazilian Amazon: A randomized controlled clinical trial
  38. Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
  39. Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil
  40. Effect of piplartine and cinnamides on Leishmania amazonensis , Plasmodium falciparum and on peritoneal cells of Swiss mice
  41. Early-onset neonatal sepsis and the implementation of group B streptococcus prophylaxis in a Brazilian maternity hospital: a descriptive study
  42. Rapid diagnostic test for G6PD deficiency in Plasmodium vivax -infected men: a budget impact analysis based in Brazilian Amazon
  43. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon
  44. Could Plasmodium vivax malaria trigger malnutrition? Revisiting the Bradford Hill criteria to assess a causal relationship between two neglected problems
  45. Are opossums a relevant factor associated with asymptomatic Leishmania infection in the outskirts of the largest Brazilian cities?
  46. Sensitivity and specificity of parallel or serial serological testing for detection of canine Leishmania infection
  47. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon
  48. O controle de leishmaniose visceral no Brasil: transformar é preciso
  49. Successful isolation of Leishmania infantum from Rhipicephalus sanguineus sensu lato (Acari: Ixodidae) collected from naturally infected dogs
  50. Polymerase chain reaction-based method for the identification of Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in mucosal tissues conserved in paraffin
  51. Leishmania (Viannia) naiffi: rare enough to be neglected?
  52. Epidemiological transition of tropical diseases in the Brazilian Amazon
  53. Tegumentary leishmaniasis in the State of Amazonas: what have we learned and what do we need?
  54. G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study
  55. Expanding the knowledge about Leishmania species in wild mammals and dogs in the Brazilian savannah
  56. Diagnostic tests for canine visceral leishmaniasis
  57. Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil
  58. Visceral Leishmaniasis and HIV Coinfection in Latin America
  59. G6PD deficiency in Latin America: systematic review on prevalence and variants
  60. Accuracy and reproducibility of a rapid chromatographic immunoassay for the diagnosis of canine visceral leishmaniasis in Brazil
  61. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes
  62. Validity and Reliability of Enzyme Immunoassays Using Leishmania major or L. infantum Antigens for the Diagnosis of Canine Visceral Leishmaniasis in Brazil
  63. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil
  64. Interventions for American Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review Update
  65. Congenitally transmitted visceral leishmaniasis: report of two Brazilian human cases
  66. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil
  67. Clinical research monitoring: scenarios and challenges
  68. Development and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identificatio nof the parasite species
  69. Mediastinitis and pericardial effusion in a patient with AIDS and disseminated Mycobacterium avium infection: a case report
  70. Cost-effectiveness of diagnostic for malaria in Extra-Amazon Region, Brazil
  71. Multi-centric prospective evaluation of rk39 rapid test and direct agglutination test for the diagnosis of visceral leishmaniasis in Brazil
  72. Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients
  73. Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes
  74. Investigation of plant extracts in traditional medicine of the Brazilian Cerrado against protozoans and yeasts
  75. Control of Visceral Leishmaniasis in Latin America—A Systematic Review
  76. Detection of Leishmania kDNA in human serum samples for the diagnosis of visceral leishmaniasis
  77. Prevalence of Leishmania infection in adult HIV/AIDS patients treated in a tertiary-level care center in Brasilia, Federal District, Brazil
  78. Oportunidades perdidas de avaliação sorológica para a infecção pelo vírus da imunodeficiência humana na rotina de atendimento ambulatorial do Hospital Universitário de Brasília, Distrito Federal
  79. Sensitivity and reproducibility of a PCR assay for Leishmania detection using skin biopsy imprints on filter paper
  80. Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District
  81. Efeito de uma formulação hidrofílica de paromomicina tópica na leishmaniose cutânea em pacientes com contra-indicações de tratamento com antimonial pentavalente
  82. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil
  83. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial
  84. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil
  85. Identification of antigenically distinct populations of Leishmania (Viannia) guyanensis from Manaus, Brazil, using monoclonal antibodies
  86. The rarity of infection withLeishmania (Viannia) braziliensisamong patients from the Manaus region of Amazonas state, Brazil, who have cutaneous leishmaniasis
  87. Sensitivity of the polymerase chain reaction for the diagnosis of cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis
  88. Comparison of Cutaneous Leishmaniasis Due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: Clinical Findings and Diagnostic Approach
  89. Glucantime dosage